SELARL PHARMACIE DE LA JONQUIERE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE LA JONQUIERE is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FOS-SUR-MER (13270), this company of category PME shows in 2021 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE LA JONQUIERE (SIREN 534053459)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 1 907 787 € 1 841 700 € 1 842 890 € 1 865 372 € 1 784 294 € 1 724 223 €
Net income 69 308 € 102 857 € 131 771 € 94 769 € 98 750 € 101 995 € 106 113 € 91 119 €
EBITDA N/C N/C 152 223 € 114 087 € 124 498 € 137 569 € 151 304 € 142 159 €
Net margin N/C N/C 6.9% 5.1% 5.4% 5.5% 5.9% 5.3%

Revenue and income statement

In 2024, SELARL PHARMACIE DE LA JONQUIERE generates positive net income of 69 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 91 k€ -> 69 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

69 308 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

14.761%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

76.984%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

15.7%

Solvency indicators evolution
SELARL PHARMACIE DE LA JONQUIERE

Sector positioning

Debt ratio
14.76 2024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent -7 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DE LA JO... (14.76) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
76.98% 2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +11 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DE LA JO... (77.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
3.33 years 2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Good

In 2021, the repayment capacity of SELARL PHARMACIE DE LA JO... (3.33) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 163.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

163.033

Liquidity indicators evolution
SELARL PHARMACIE DE LA JONQUIERE

Sector positioning

Liquidity ratio
163.03 2024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average +17 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DE LA JO... (163.03) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
5.82x 2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Good

In 2021, the interest coverage of SELARL PHARMACIE DE LA JO... (5.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 182 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 678 days. Excellent situation: suppliers finance 496 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

182 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

678 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DE LA JONQUIERE

Positioning of SELARL PHARMACIE DE LA JONQUIERE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DE LA JONQUIERE is estimated at 967 590 € (range 673 815€ - 1 447 571€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
673k€ 967k€ 1447k€
967 590 € Range: 673 815€ - 1 447 571€
NAF 5 année 2024

Valuation method used

Net Income Multiple
69 308 € × 14.0x = 967 591 €
Range: 673 815€ - 1 447 571€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE LA JONQUIERE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE LA JONQUIERE

What is the revenue of SELARL PHARMACIE DE LA JONQUIERE ?

The revenue of SELARL PHARMACIE DE LA JONQUIERE in 2021 is 1.9 M€.

Is SELARL PHARMACIE DE LA JONQUIERE profitable?

Yes, SELARL PHARMACIE DE LA JONQUIERE generated a net profit of 69 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DE LA JONQUIERE ?

The headquarters of SELARL PHARMACIE DE LA JONQUIERE is located in FOS-SUR-MER (13270), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE DE LA JONQUIERE ?

The tax return of SELARL PHARMACIE DE LA JONQUIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE LA JONQUIERE operate?

SELARL PHARMACIE DE LA JONQUIERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.